(Q38179536)

English

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy.

scientific article published on August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

William L. Irving

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

M Backx

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Lewszuk

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

J R White

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Sreedharan

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

S van Sanden

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

J Diels

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A Lawson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

K R Neal

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

M J Wiselka

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

208-215

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24438682%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

HCV in liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

The burden of hepatitis C in England

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

The epidemiology of hepatitis C in a UK health regional population of 5.12 million

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Resource use and cost of hepatitis C-related care

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Eradication of hepatitis C virus reduces the risk of hepatocellular carcinoma in patients with compensated cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12132

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38179536&oldid=2135781125"